VIDEO: Heart failure ‘not just a cardiovascular problem, but a metabolic problem’
Click Here to Manage Email Alerts
In this video, Ralph A. DeFronzo, MD, discusses the potential of new drugs in the cardiovascular and endocrinology specialties to help slow progression of cardiometabolic disorders for people with diabetes and chronic kidney disease.
DeFronzo, a professor of medicine and chief of the diabetes division at the University of Texas Health Sciences Center in San Antonio and director of the Diabetes Institute, gave the perspective at the Evolving Concepts in the Management of Diabetes and Cardiorenal Metabolic Diseases workshop in Dallas. The Diabetes Institute sees more than 10,000 patients a year, he said.
“In the past, cardiology, renal and diabetes have been separate entities, and although they have been interrelated, there really hasn’t been a special effort to bring these communities together,” DeFronzo told Healio. “The cardiology community has been hemodynamically oriented, the diabetes community has been metabolically oriented, but what we have come to learn is the prevention of heart failure and the prevention of atherosclerosis is not just a cardiovascular problem, it is a metabolic problem.”
Collapse
Click Here to Manage Email Alerts